Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 203

1.

The Italian multiple sclerosis register.

Trojano M, Bergamaschi R, Amato MP, Comi G, Ghezzi A, Lepore V, Marrosu MG, Mosconi P, Patti F, Ponzio M, Zaratin P, Battaglia MA; Italian Multiple Sclerosis Register Centers Group.

Neurol Sci. 2019 Jan;40(1):155-165. doi: 10.1007/s10072-018-3610-0. Epub 2018 Nov 13.

2.

Ein weiblicher Säugling mit papulovesikulären Läsionen.

Veronese F, Zavattaro E, Monzani A, Zaffaroni M, Landucci G, De Miglio L, Nugnes M, Savoia P.

J Dtsch Dermatol Ges. 2018 Nov;16(11):1383-1386. doi: 10.1111/ddg.13643_g. No abstract available.

PMID:
30395391
3.

No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study.

Prosperini L, Annovazzi P, Boffa L, Buscarinu MC, Gallo A, Matta M, Moiola L, Musu L, Perini P, Avolio C, Barcella V, Bianco A, Farina D, Ferraro E, Pontecorvo S, Granella F, Grimaldi LME, Laroni A, Lus G, Patti F, Pucci E, Pasca M, Sarchielli P; Italian Alemtuzumab Study Group.

J Neurol. 2018 Dec;265(12):2851-2860. doi: 10.1007/s00415-018-9070-x. Epub 2018 Sep 26.

PMID:
30259178
4.

Trial of Fingolimod versus Interferon Beta-1a in Pediatric Multiple Sclerosis.

Chitnis T, Arnold DL, Banwell B, Brück W, Ghezzi A, Giovannoni G, Greenberg B, Krupp L, Rostásy K, Tardieu M, Waubant E, Wolinsky JS, Bar-Or A, Stites T, Chen Y, Putzki N, Merschhemke M, Gärtner J; PARADIGMS Study Group.

N Engl J Med. 2018 Sep 13;379(11):1017-1027. doi: 10.1056/NEJMoa1800149.

PMID:
30207920
5.

A female newborn with papulovesicular lesions.

Veronese F, Zavattaro E, Monzani A, Zaffaroni M, Landucci G, De Miglio L, Nugnes M, Savoia P.

J Dtsch Dermatol Ges. 2018 Nov;16(11):1383-1386. doi: 10.1111/ddg.13643. Epub 2018 Aug 29. No abstract available.

PMID:
30157313
6.

Two-year real-life efficacy, tolerability and safety of dimethyl fumarate in an Italian multicentre study.

Mallucci G, Annovazzi P, Miante S, Torri-Clerici V, Matta M, La Gioia S, Cavarretta R, Mantero V, Costantini G, D'Ambrosio V, Zaffaroni M, Ghezzi A, Perini P, Rossi S, Bertolotto A, Rottoli MR, Rovaris M, Balgera R, Cavalla P, Montomoli C, Bergamaschi R.

J Neurol. 2018 Aug;265(8):1850-1859. doi: 10.1007/s00415-018-8916-6. Epub 2018 Jun 14.

PMID:
29948245
7.

Dopaminergic Stimulation of Myeloid Antigen-Presenting Cells Attenuates Signal Transducer and Activator of Transcription 3-Activation Favouring the Development of Experimental Autoimmune Encephalomyelitis.

Prado C, Gaiazzi M, González H, Ugalde V, Figueroa A, Osorio-Barrios FJ, López E, Lladser A, Rasini E, Marino F, Zaffaroni M, Cosentino M, Pacheco R.

Front Immunol. 2018 Mar 21;9:571. doi: 10.3389/fimmu.2018.00571. eCollection 2018.

8.

Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension.

Kapoor R, Ho PR, Campbell N, Chang I, Deykin A, Forrestal F, Lucas N, Yu B, Arnold DL, Freedman MS, Goldman MD, Hartung HP, Havrdová EK, Jeffery D, Miller A, Sellebjerg F, Cadavid D, Mikol D, Steiner D; ASCEND investigators.

Lancet Neurol. 2018 May;17(5):405-415. doi: 10.1016/S1474-4422(18)30069-3. Epub 2018 Mar 12.

PMID:
29545067
9.

Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risks.

Portaccio E, Annovazzi P, Ghezzi A, Zaffaroni M, Moiola L, Martinelli V, Lanzillo R, Brescia Morra V, Rinaldi F, Gallo P, Tortorella C, Paolicelli D, Pozzilli C, De Giglio L, Cavalla P, Cocco E, Marrosu MG, Patti F, Solaro C, Bellantonio P, Uccelli A, Laroni A, Pastò L, Giannini M, Trojano M, Comi G, Amato MP; MS Study Group of the Italian Neurological Society.

Neurology. 2018 Mar 6;90(10):e823-e831. doi: 10.1212/WNL.0000000000005067. Epub 2018 Feb 7.

PMID:
29438046
10.

Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: II: Maternal risks.

Portaccio E, Moiola L, Martinelli V, Annovazzi P, Ghezzi A, Zaffaroni M, Lanzillo R, Brescia Morra V, Rinaldi F, Gallo P, Tortorella C, Paolicelli D, Pozzilli C, De Giglio L, Cavalla P, Cocco E, Marrosu MG, Solaro C, Uccelli A, Laroni A, Pastò L, Giannini M, Trojano M, Comi G, Amato MP; MS Study Group of the Italian Neurological Society.

Neurology. 2018 Mar 6;90(10):e832-e839. doi: 10.1212/WNL.0000000000005068. Epub 2018 Feb 7.

PMID:
29438041
11.

Italian multicentre study found infectious and vaccine-preventable diseases in children adopted from Africa and recommends prompt medical screening.

Chiappini E, Zaffaroni M, Bianconi M, Veneruso G, Grasso N, Garazzino S, Arancio R, Valentini P, Ficcadenti A, Da Riol MR, La Placa S, Galli L, de Martino M, Bona G.

Acta Paediatr. 2018 Jan 24. doi: 10.1111/apa.14237. [Epub ahead of print]

PMID:
29364534
12.

Long-term follow-up of pediatric MS patients starting treatment with injectable first-line agents: A multicentre, Italian, retrospective, observational study.

Baroncini D, Zaffaroni M, Moiola L, Lorefice L, Fenu G, Iaffaldano P, Simone M, Fanelli F, Patti F, D'Amico E, Capobianco M, Bertolotto A, Gallo P, Margoni M, Miante S, Milani N, Amato MP, Righini I, Bellantonio P, Scandellari C, Costantino G, Scarpini E, Bergamaschi R, Mallucci G, Comi G, Ghezzi A; iMED Registry and Gruppo di Studio SM-Società Italiana di Neurologia.

Mult Scler. 2018 Jan 1:1352458518754364. doi: 10.1177/1352458518754364. [Epub ahead of print]

PMID:
29363396
13.

Cerebrospinal fluid analysis and the determination of oligoclonal bands.

Gastaldi M, Zardini E, Leante R, Ruggieri M, Costa G, Cocco E, De Luca G, Cataldo I, Biagioli T, Ballerini C, Castellazzi M, Fainardi E, Pettini P, Zaffaroni M, Giunti D, Capello E, Bernardi G, Ciusani E, Giannotta C, Nobile-Orazio E, Bazzigaluppi E, Passerini G, Bedin R, Sola P, Brivio R, Cavaletti G, Sala A, Bertolotto A, Desina G, Leone MA, Mariotto S, Ferrari S, Paternoster A, Giavarina D, Lolli F, Franciotta D.

Neurol Sci. 2017 Oct;38(Suppl 2):217-224. doi: 10.1007/s10072-017-3034-2. Review.

PMID:
29030765
14.

Vitamin D status in internationally adopted children: the experience in Northwest Italy.

Raffaldi I, Garazzino S, Ballardini G, Zaffaroni M, Grasso N, Bona G, Tovo PA, Guala A.

Minerva Pediatr. 2017 Sep 15. doi: 10.23736/S0026-4946.17.04883-6. [Epub ahead of print]

PMID:
28922908
15.

Sativex in resistant multiple sclerosis spasticity: Discontinuation study in a large population of Italian patients (SA.FE. study).

Messina S, Solaro C, Righini I, Bergamaschi R, Bonavita S, Bossio RB, Brescia Morra V, Costantino G, Cavalla P, Centonze D, Comi G, Cottone S, Danni MC, Francia A, Gajofatto A, Gasperini C, Zaffaroni M, Petrucci L, Signoriello E, Maniscalco GT, Spinicci G, Matta M, Mirabella M, Pedà G, Castelli L, Rovaris M, Sessa E, Spitaleri D, Paolicelli D, Granata A, Zappia M, Patti F; SA.FE. study group.

PLoS One. 2017 Aug 1;12(8):e0180651. doi: 10.1371/journal.pone.0180651. eCollection 2017.

16.

Hypomagnesaemia as a trigger of relapsing non-alcoholic Wernicke encephalopathy: a case report.

Baroncini D, Annovazzi P, Minonzio G, Franzetti I, Zaffaroni M.

Neurol Sci. 2017 Nov;38(11):2069-2071. doi: 10.1007/s10072-017-3062-y. Epub 2017 Jul 20. No abstract available.

PMID:
28730572
17.

Dataset of mRNA levels for dopaminergic receptors, adrenoceptors and tyrosine hydroxylase in lymphocytes from subjects with clinically isolated syndromes.

Cosentino M, Zaffaroni M, Legnaro M, Bombelli R, Schembri L, Baroncini D, Bianchi A, Clerici R, Guidotti M, Banfi P, Bono G, Marino F.

Data Brief. 2016 Sep 17;9:376-381. eCollection 2016 Dec.

18.

Dopaminergic receptors and adrenoceptors in circulating lymphocytes as putative biomarkers for the early onset and progression of multiple sclerosis.

Cosentino M, Zaffaroni M, Legnaro M, Bombelli R, Schembri L, Baroncini D, Bianchi A, Clerici R, Guidotti M, Banfi P, Bono G, Marino F.

J Neuroimmunol. 2016 Sep 15;298:82-9. doi: 10.1016/j.jneuroim.2016.07.008. Epub 2016 Jul 7.

PMID:
27609280
19.

Variations in multiple sclerosis practice within Europe - Is it time for a new treatment guideline?

Marziniak M, Ghorab K, Kozubski W, Pfleger C, Sousa L, Vernon K, Zaffaroni M, Meuth SG.

Mult Scler Relat Disord. 2016 Jul;8:35-44. doi: 10.1016/j.msard.2016.04.004. Epub 2016 Apr 12. Review.

PMID:
27456872
20.

Natalizumab versus fingolimod in patients with relapsing-remitting multiple sclerosis non-responding to first-line injectable therapies.

Baroncini D, Ghezzi A, Annovazzi PO, Colombo B, Martinelli V, Minonzio G, Moiola L, Rodegher M, Zaffaroni M, Comi G.

Mult Scler. 2016 Sep;22(10):1315-26. doi: 10.1177/1352458516650736. Epub 2016 May 26.

PMID:
27230789
21.

Use of herbal remedies by multiple sclerosis patients: a nation-wide survey in Italy.

Loraschi A, Bellantonio P, Bortolon F, Capra R, Cavalla P, Costantino G, Lugaresi A, Martinelli V, Marrosu MG, Patti F, Rottoli M, Salvetti M, Sola P, Solaro C, Klersy C, Marino F, Zaffaroni M, Cosentino M.

Neurol Sci. 2016 Apr;37(4):613-22. doi: 10.1007/s10072-016-2519-8. Epub 2016 Feb 19.

PMID:
26895323
22.

High Prevalence of Vitamin D Deficiency in Native versus Migrant Mothers and Newborns in the North of Italy: A Call to Act with a Stronger Prevention Program.

Cadario F, Savastio S, Magnani C, Cena T, Pagliardini V, Bellomo G, Bagnati M, Vidali M, Pozzi E, Pamparana S, Zaffaroni M, Genoni G, Bona G.

PLoS One. 2015 Jun 11;10(6):e0129586. doi: 10.1371/journal.pone.0129586. eCollection 2015.

23.

Extrahepatic sources of factor VIII potentially contribute to the coagulation cascade correcting the bleeding phenotype of mice with hemophilia A.

Zanolini D, Merlin S, Feola M, Ranaldo G, Amoruso A, Gaidano G, Zaffaroni M, Ferrero A, Brunelleschi S, Valente G, Gupta S, Prat M, Follenzi A.

Haematologica. 2015 Jul;100(7):881-92. doi: 10.3324/haematol.2014.123117. Epub 2015 Apr 24.

24.

Neonatal screening for sickle cell disease and other hemoglobinopathies in "the changing Europe".

Rolla R, Castagno M, Zaffaroni M, Grigollo B, Colombo S, Piccotti S, Dellora C, Bona G, Bellomo G.

Clin Lab. 2014;60(12):2089-93.

PMID:
25651745
25.

Levels of mRNA for dopaminergic receptor D₅ in circulating lymphocytes may be associated with subsequent response to interferon-β in patients with multiple sclerosis.

Cosentino M, Zaffaroni M, Marino F.

J Neuroimmunol. 2014 Dec 15;277(1-2):193-6. doi: 10.1016/j.jneuroim.2014.10.009. Epub 2014 Oct 31.

PMID:
25468276
26.

Uhthoff's phenomena and brain MRI suggesting demyelinating lesions: RIS or CIS? A case report.

Baroncini D, Zaffaroni M, Minonzio G, Annovazzi P, Baldini SM, Comi G, Ghezzi A.

J Neurol Sci. 2014 Oct 15;345(1-2):262-4. doi: 10.1016/j.jns.2014.07.020. Epub 2014 Jul 16. No abstract available.

PMID:
25064443
27.

MxA mRNA quantification and disability progression in interferon beta-treated multiple sclerosis patients.

Serana F, Imberti L, Amato MP, Comi G, Gasperini C, Ghezzi A, Martinelli V, Provinciali L, Rottoli MR, Sotgiu S, Stecchi S, Vecchio M, Zaffaroni M, Cordioli C, Capra R.

PLoS One. 2014 Apr 14;9(4):e94794. doi: 10.1371/journal.pone.0094794. eCollection 2014.

28.

Postpartum relapses increase the risk of disability progression in multiple sclerosis: the role of disease modifying drugs.

Portaccio E, Ghezzi A, Hakiki B, Sturchio A, Martinelli V, Moiola L, Patti F, Mancardi GL, Solaro C, Tola MR, Pozzilli C, De Giglio L, Totaro R, Lugaresi A, De Luca G, Paolicelli D, Marrosu MG, Comi G, Trojano M, Amato MP; MS Study Group of the Italian Neurological Society.

J Neurol Neurosurg Psychiatry. 2014 Aug;85(8):845-50. doi: 10.1136/jnnp-2013-306054. Epub 2014 Jan 8.

PMID:
24403285
29.

Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study group.

Bertolotto A, Capobianco M, Amato MP, Capello E, Capra R, Centonze D, Di Ioia M, Gallo A, Grimaldi L, Imberti L, Lugaresi A, Mancinelli C, Marrosu MG, Moiola L, Montanari E, Romano S, Musu L, Paolicelli D, Patti F, Pozzilli C, Rossi S, Salvetti M, Tedeschi G, Tola MR, Trojano M, Zaffaroni M, Malucchi S; Italian Multiple Sclerosis Study group.

Neurol Sci. 2014 Feb;35(2):307-16. doi: 10.1007/s10072-013-1616-1. Epub 2013 Dec 29. Erratum in: Neurol Sci. 2014 Oct;35(10):1645-6. Troiano, Maria [corrected to Trojano, Maria].

PMID:
24374787
30.

Growth hormone and disease severity in early stage of multiple sclerosis.

Gironi M, Solaro C, Meazza C, Vaghi M, Montagna L, Rovaris M, Batocchi AP, Nemni R, Albertini R, Zaffaroni M, Bozzola M.

Mult Scler Int. 2013;2013:836486. doi: 10.1155/2013/836486. Epub 2013 Oct 23.

31.

Subcutaneous interferon β-1a may protect against cognitive impairment in patients with relapsing-remitting multiple sclerosis: 5-year follow-up of the COGIMUS study.

Patti F, Morra VB, Amato MP, Trojano M, Bastianello S, Tola MR, Cottone S, Plant A, Picconi O; COGIMUS Study Group.

PLoS One. 2013 Aug 30;8(8):e74111. doi: 10.1371/journal.pone.0074111. eCollection 2013.

32.

[What new fathers know, think and do: a survey about fathering's attitudes, beliefs and behaviors in a sample of 570 men just after the birth of their newborn].

Pellai A, Festa F, Cilento F, Grossi L, Grassino E, Zaffaroni M, Guidi C, Bona G, Bonomi A, Visentin R, Angellotti P, Guala A.

Minerva Pediatr. 2013 Oct;65(5):531-40. Italian.

PMID:
24056379
33.

Detection of clinical relapses in multiple sclerosis cohorts: construction and validation of a model based on administrative data.

Bergamaschi R, Agnello M, Colombo E, Della Giovanna M, Montomoli C, Nava A, Perotti P, Riva M, Ruggeri I, Scola R, Silvestri MG, Tringali M, Uggeri B, Violante G, Zaffaroni M.

Neurol Sci. 2014 Feb;35(2):265-9. doi: 10.1007/s10072-013-1503-9. Epub 2013 Jul 20.

PMID:
23873521
34.

Vitamin D status in cord blood and newborns: ethnic differences.

Cadario F, Savastio S, Pozzi E, Capelli A, Dondi E, Gatto M, Zaffaroni M, Bona G.

Ital J Pediatr. 2013 Jun 4;39:35. doi: 10.1186/1824-7288-39-35.

35.

Natalizumab in pediatric multiple sclerosis: results of a cohort of 55 cases.

Ghezzi A, Pozzilli C, Grimaldi LM, Moiola L, Brescia-Morra V, Lugaresi A, Lus G, Rinaldi F, Rocca MA, Trojano M, Bianchi A, Comi G, Filippi M; Italian MS Study Group.

Mult Scler. 2013 Jul;19(8):1106-12. doi: 10.1177/1352458512471878. Epub 2013 Feb 11.

PMID:
23401129
36.

Disease reactivation after fingolimod discontinuation in two multiple sclerosis patients.

Ghezzi A, Rocca MA, Baroncini D, Annovazzi P, Zaffaroni M, Minonzio G, Comi G, Filippi M.

J Neurol. 2013 Jan;260(1):327-9. doi: 10.1007/s00415-012-6744-7. Epub 2012 Nov 16. No abstract available.

PMID:
23161460
37.

Dopaminergic modulation of CD4+CD25(high) regulatory T lymphocytes in multiple sclerosis patients during interferon-β therapy.

Cosentino M, Zaffaroni M, Trojano M, Giorelli M, Pica C, Rasini E, Bombelli R, Ferrari M, Ghezzi A, Comi G, Livrea P, Lecchini S, Marino F.

Neuroimmunomodulation. 2012;19(5):283-92. doi: 10.1159/000336981. Epub 2012 Apr 3.

PMID:
22472872
38.

Patient adherence to and tolerability of self-administered interferon β-1a using an electronic autoinjection device: a multicentre, open-label, phase IV study.

Lugaresi A, Florio C, Brescia-Morra V, Cottone S, Bellantonio P, Clerico M, Centonze D, Uccelli A, di Ioia M, De Luca G, Marcellusi A, Paolillo A; BRIDGE study group.

BMC Neurol. 2012 Mar 5;12:7. doi: 10.1186/1471-2377-12-7.

39.

Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone.

Martinelli V, Cocco E, Capra R, Salemi G, Gallo P, Capobianco M, Pesci I, Ghezzi A, Pozzilli C, Lugaresi A, Bellantonio P, Amato MP, Grimaldi LM, Trojano M, Mancardi GL, Bergamaschi R, Gasperini C, Rodegher M, Straffi L, Ponzio M, Comi G; Italian Mitoxantrone Group.

Neurology. 2011 Nov 22;77(21):1887-95. doi: 10.1212/WNL.0b013e318238ee00. Epub 2011 Nov 9.

PMID:
22076543
40.

Changes in magnetic resonance imaging disease measures over 3 years in mildly disabled patients with relapsing-remitting multiple sclerosis receiving interferon β-1a in the COGnitive Impairment in MUltiple Sclerosis (COGIMUS) study.

Bastianello S, Giugni E, Amato MP, Tola MR, Trojano M, Galletti S, Luccichenti G, Quarantelli M, Picconi O, Patti F; COGIMUS study group.

BMC Neurol. 2011 Oct 14;11:125. doi: 10.1186/1471-2377-11-125.

41.

Recommendations for the management of urinary disorders in multiple sclerosis: a consensus of the Italian Multiple Sclerosis Study Group.

Ghezzi A, Carone R, Del Popolo G, Amato MP, Bertolotto A, Comola M, Del Carro U, Di Benedetto P, Giannantoni A, Lopes de Carvalho ML, Montanari E, Patti F, Protti A, Rasia S, Salonia A, Scandellari C, Sperli F, Spinelli M, Solaro C, Uccelli A, Zaffaroni M, Zipoli V; Multiple Sclerosis Study Group, Italian Society of Neurology.

Neurol Sci. 2011 Dec;32(6):1223-31. doi: 10.1007/s10072-011-0794-y.

PMID:
21948057
42.

Breastfeeding is not related to postpartum relapses in multiple sclerosis.

Portaccio E, Ghezzi A, Hakiki B, Martinelli V, Moiola L, Patti F, La Mantia L, Mancardi GL, Solaro C, Tola MR, Pozzilli C, De Giglio L, Totaro R, Lugaresi A, De Luca G, Paolicelli D, Marrosu MG, Comi G, Trojano M, Amato MP; MS Study Group of the Italian Neurological Society.

Neurology. 2011 Jul 12;77(2):145-50. doi: 10.1212/WNL.0b013e318224afc9. Epub 2011 Jul 6.

PMID:
21734184
43.

The direct cost of patients with multiple sclerosis: a survey from Italian MS centres.

P B, M P A, P B, F B, P C, C F, A L, E M, M R, I L S, M Z.

Neurol Sci. 2011 Dec;32(6):1035-41. doi: 10.1007/s10072-011-0578-4. Epub 2011 Apr 20.

PMID:
21505911
44.

Quality of life, depression and fatigue in mildly disabled patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: 3-year results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study.

Patti F, Amato MP, Trojano M, Bastianello S, Tola MR, Picconi O, Cilia S, Cottone S, Centonze D, Gasperini C; COGIMUS Study Group.

Mult Scler. 2011 Aug;17(8):991-1001. doi: 10.1177/1352458511401943. Epub 2011 Apr 18.

PMID:
21502310
45.

Serological evidence of vertical transmission of JC and BK polyomaviruses in humans.

Boldorini R, Allegrini S, Miglio U, Paganotti A, Cocca N, Zaffaroni M, Riboni F, Monga G, Viscidi R.

J Gen Virol. 2011 May;92(Pt 5):1044-50. doi: 10.1099/vir.0.028571-0. Epub 2011 Feb 9.

PMID:
21307224
46.

Intrathecal baclofen in multiple sclerosis: too little, too late?

Erwin A, Gudesblatt M, Bethoux F, Bennett SE, Koelbel S, Plunkett R, Sadiq S, Stevenson VL, Thomas AM, Tornatore C, Zaffaroni M, Hughes M.

Mult Scler. 2011 May;17(5):623-9. doi: 10.1177/1352458510395056. Epub 2011 Jan 31. Review.

PMID:
21282321
47.

Phase III dose-comparison study of glatiramer acetate for multiple sclerosis.

Comi G, Cohen JA, Arnold DL, Wynn D, Filippi M; FORTE Study Group.

Ann Neurol. 2011 Jan;69(1):75-82. doi: 10.1002/ana.22316.

PMID:
21280077
48.

Pregnancy and fetal outcomes after interferon-β exposure in multiple sclerosis.

Amato MP, Portaccio E, Ghezzi A, Hakiki B, Zipoli V, Martinelli V, Moiola L, Patti F, La Mantia L, Mancardi GL, Solaro C, Tola MR, Pozzilli C, De Giglio L, Totaro R, Lugaresi A, Di Tommaso V, Paolicelli D, Marrosu MG, Comi G, Pellegrini F, Trojano M; MS Study Group of the Italian Neurological Society.

Neurology. 2010 Nov 16;75(20):1794-802. doi: 10.1212/WNL.0b013e3181fd62bb.

PMID:
21079181
49.

Congenital syphilis in Italy: a multicentre study.

Tridapalli E, Capretti MG, Reggiani ML, Stronati M, Faldella G; Italian Neonatal Task Force of Congenital Syphilis for The Italian Society of Neonatology – Collaborative Group.

Arch Dis Child Fetal Neonatal Ed. 2012 May;97(3):F211-3. doi: 10.1136/adc.2010.183863. Epub 2010 Sep 24.

PMID:
20870907
50.

Oral laquinimod in patients with relapsing-remitting multiple sclerosis: 36-week double-blind active extension of the multi-centre, randomized, double-blind, parallel-group placebo-controlled study.

Comi G, Abramsky O, Arbizu T, Boyko A, Gold R, Havrdová E, Komoly S, Selmaj K, Sharrack B, Filippi M; LAQ/5063 Study Group.

Mult Scler. 2010 Nov;16(11):1360-6. doi: 10.1177/1352458510378127. Epub 2010 Sep 8.

PMID:
20834039

Supplemental Content

Loading ...
Support Center